Regenerative medicine for the eye utilizes iPS cell-derived retinal organoids to address degenerative conditions like retinitis pigmentosa and macular degeneration. Dr. Ryutaro Akiba, an ophthalmologist and researcher at Chiba University, explains that the eye serves as an ideal model for neural repair due to its accessibility and the sophisticated nature of retinal circuits. While gene therapy offers potential for early-stage intervention, cell transplantation remains critical for advanced degeneration where photoreceptors are lost. Current research focuses on overcoming the "Death Valley" of clinical translation, specifically by enhancing synapse formation through genetic engineering and leveraging neuroplasticity to restore visual function. Beyond specific medical applications, the discussion highlights the broader necessity of curiosity-driven basic research and the challenges of securing funding for long-term innovation within the Japanese academic landscape.
Sign in to continue reading, translating and more.
Open full episode in Podwise